Trabectedin and Radiation Therapy for Cardiac Metastasis From Leiomyosarcoma: A Case Report and Review of the Literature

Ilaria Tortorelli(University of Padua), Antonella Brunello(Istituto Oncologico Veneto), Vittorina Zagonel, Benedetta Chiusole(Istituto Oncologico Veneto), Luca Nicosia(Ospedale Sacro Cuore Don Calabria), A. Banzato(Istituto Oncologico Veneto), Federico Navarria(Centro di Riferimento Oncologico), Marta Sbaraglia(University of Padua), Antonella Galiano(Istituto Oncologico Veneto), Antonio Di Maggio(Istituto Oncologico Veneto), Chiara Lestuzzi
Frontiers in Oncology
April 28, 2022
10.3389/fonc.2022.838114
Cited by 3

Related Papers

Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
|New England Journal of Medicine|2014|1.1k
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial
|The Lancet Oncology|2020|322
Assessment of a HER2 scoring system for colorectal cancer: results from a validation study
|Modern Pathology|2015|317
Nutritional Support in Cancer Patients: A Position Paper from the Italian Society of Medical Oncology (AIOM) and the Italian Society of Artificial Nutrition and Metabolism (SINPE)
|Journal of Cancer|2015|144